Brady Corporation — Form 10-Q Summary
Business context and reporting period
Fiscal 2024 first quarter, three months ended October 31, 2023; comparisons are with the three months ended October 31, 2022 unless otherwise noted. Brady manufactures and supplies identification solutions and workplace safety products. Its reportable segments are Americas & Asia and Europe & Australia.
Financial performance
| Metric | Q1 FY2024 | Q1 FY2023 |
|---|---|---|
| Net sales | $332.0 million | $322.6 million |
| Gross profit / margin | $171.7 million / 51.7% | $155.3 million / 48.1% |
| Operating income / margin | $59.7 million / 18.0% | $51.4 million / 15.9% |
| Net income / net margin | $47.2 million / 14.2% | $39.4 million / 12.2% |
| Diluted EPS, Class A | $0.97 | $0.79 |
| Operating cash flow | $62.3 million | $28.0 million |
| Capital expenditures | $11.3 million | $3.9 million |
Sales increased 2.9%: organic growth of 2.7% and favorable currency translation of 1.5% were partly offset by a 1.3% impact from divestitures. Gross margin improvement was attributed mainly to product mix, lower freight costs, and better inventory management. R&D rose to $15.7 million (4.7% of sales), while SG&A rose to $96.3 million (29.0% of sales), reflecting increased staffing and investment, currency effects, and digital advertising.
- Segments: Americas & Asia sales were $221.6 million, up 1.4%; organic sales grew 3.3%, and segment profit increased 21.3% to $49.9 million. Europe & Australia sales were $110.4 million, up 6.0% including 4.6% currency benefit; organic sales grew 1.4%, while segment profit was essentially flat at $16.7 million.
- Cash and liquidity: Cash was $175.4 million at October 31, 2023, up $23.8 million from July 31. Management reported $245.8 million available under the credit agreement and potential capacity to increase it, subject to conditions, for stated total available liquidity of $1,266.1 million. Approximately 98% of cash was held outside the U.S.
- Debt: Long-term debt was $52.3 million. The company reported compliance with covenants: debt-to-EBITDA of 0.18x against a 3.5x maximum and interest coverage of 82.0x against a 3.0x minimum.
- Capital returns: The company repurchased 279,683 shares for approximately $14.1 million in the quarter and paid $11.3 million in dividends. A $0.235-per-share quarterly dividend was declared after quarter-end, payable January 31, 2024.
Material changes, outlook, and risks
Compared with the prior-year quarter, profitability and cash generation improved, while sales growth was modest. Divestitures affected year-over-year comparability in Americas & Asia. Americas & Asia benefited from sales volume, lower freight, and manufacturing efficiencies; Europe & Australia faced inflation in labor and other costs. Operating cash flow improved partly because inventory declined, whereas prior-year inventory had been elevated.
Management says it expects continued inflationary pressures and supply-chain and other business disruptions, which it seeks to mitigate through pricing and efficiency measures. Its stated priorities include product development, customer service, digital sales capabilities, acquisition integration, and operational efficiency. Management believes liquidity is adequate for anticipated needs, including working capital, capital spending, R&D, repurchases, and dividends. The filing gives no specific sales or earnings forecast; it says the ongoing annual tax rate is expected to be approximately 22% under current conditions.
Risks cited include inflation and supply disruptions, reduced product demand, competition and execution of strategy, cybersecurity, acquisition integration and divested-business liabilities, foreign currency movements, litigation, regulation, and potential goodwill or intangible-asset write-offs. The company said legal proceedings are not expected to have a material adverse effect and reported no material changes to the risk factors in its prior Form 10-K.
Important facts for investors to verify
- Whether organic sales growth persists, particularly given weakness in Asia and healthcare identification and the effects of divestitures.
- Whether improved gross margin and operating cash flow are sustainable as inflation, labor costs, and supply conditions evolve.
- Credit-agreement availability, covenant compliance, foreign-held cash and any costs of repatriating funds.
- Capital allocation, including repurchases, dividends, and facility construction spending.
- The impact of currency fluctuations, acquisitions or divestitures, and other risks disclosed in the company’s Form 10-K.